The pharmaceutical industry is looking for answers as the government shutdown, if it lasts longer, could threaten decisions on highly anticipated new drugs; a federal judge in Philadelphia issued a nationwide injunction that prevents the Trump administration from blocking women’s access to free birth control guaranteed under the Affordable Care Act; providers are trying to strike a balance between informing their patients about the Trump administration’s proposed “public charge” rule while not causing undue concern about their immigration status.
The pharmaceutical industry is looking for answers as the government shutdown, if it lasts longer, could threaten decisions on highly anticipated new drugs, according to a STAT analysis. The list includes medicines from Janssen, Sanofi, and Novartis for depression, diabetes, and multiple sclerosis, as well as GlaxoSmithKline’s HIV treatment. FDA Commissioner Scott Gottlieb, MD, has warned the agency only has about 3 more weeks’ worth of funding to draw down. Separately, the FDA may restart inspections of high-risk foods as early as Tuesday, as furloughed inspectors have agreed to come back to work without pay, Gottlieb tweeted on Monday.A federal judge in Philadelphia, Wendy Beetlestone, issued a nationwide injunction that prevents the Trump administration from blocking women’s access to free birth control guaranteed under the Affordable Care Act, The New York Times reported. Her decision came a day after a California federal judge granted a request by 13 states and the District of Columbia to block the rules in their jurisdictions. It’s the latest setback for the administration as it tries to allow employers to deny insurance coverage of contraceptives if they object on religious or moral grounds.Providers are trying to strike a balance between informing their patients about the Trump administration’s proposed “public charge” rule while not causing undue concern about their immigration status, Kaiser Health News reported. The proposed rule, which is awaiting final action by the Department of Homeland Security, would allow the federal government to consider immigrants’ use of an expanded list of public benefit programs including Medicaid and Section 8 housing as a reason to deny lawful permanent residency.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More